The Food and Drugs Authority (FDA) has issued a warning to the Ghanaian public about the use of Polyfort Suspension following its recall in Nigeria.
Polyfort Suspension, an antacid used to treat heartburn, indigestion and hyperacidity, is manufactured in Nigeria by Swiss Pharma Limited.
Read also
According to a statement by the FDA, the recall was due to negative results from a series of ongoing stability tests.
The statement further noted that the FDA Ghana had not registered the product, and urged anyone who came across it in trade in Ghana to report to any of the FDA's offices across the country.
The FDA's surveillance team was also actively monitoring the country's ports of entry and markets to ensure that such unregistered products were not available in the country.
In addition, the FDA advised the public to check the registration status of regulated products on the FDA website, http://fdaghana.gov.gh, or through the ProPer platform – https://bit.ly/ProPerFDA before purchase.
The public can also contact the FDA on any of its contacts on 0551112224/05551112225 on WhatsApp 0551112224 for further information.
Thanks for reading and supporting The Ghanaian Standard. Your comments on this story are welcome, kindly share them in comments section below.
Send us your press releases and news stories at [email protected], or via WhatsApp on +233550919202.
Follow GhStandard on 
